Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

被引：0

作者：

Yoichi Aoki

Kazunori Ochiai

Soyi Lim

Daisuke Aoki

Shoji Kamiura

Hao Lin

Noriyuki Katsumata

Soon-Do Cha

Jae-Hoon Kim

Byoung-Gie Kim

Yasuyuki Hirashima

Keiichi Fujiwara

Young-Tak Kim

Seok Mo Kim

Hyun Hoon Chung

Ting-Chang Chang

Toshiharu Kamura

Ken Takizawa

Masahiro Takeuchi

Soon-Beom Kang

机构：

[1] University of the Ryukyus,Department of Obstetrics and Gynecology, Graduate School of Medical Science

[2] The Jikei University School of Medicine,Department of Obstetrics and Gynecology

[3] Gachon University Gil Medical Center,Department of Obstetrics and Gynecology

[4] Keio University School of Medicine,Department of Obstetrics and Gynecology

[5] Osaka International Cancer Institute,Department of Gynecology

[6] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Obstetrics and Gynecology

[7] National Cancer Center Hospital,Department of Breast and Medical Oncology

[8] Keimyung University School of Medicine,Department of Obstetrics and Gynecology

[9] Yonsei University College of Medicine,Department of Obstetrics and Gynecology

[10] Sungkyunkwan University School of Medicine,Department of Obstetrics and Gynecology, Samsung Medical Center

[11] Shizuoka Cancer Center,Department of Gynecology

[12] Saitama Medical University International Medical Center,Department of Gynecologic Oncology

[13] Asan Medical Center,Department of Obstetrics and Gynecology

[14] Chonnam National University Hwasun Hospital,Department of Obstetrics and Gynecology

[15] Seoul National University College of Medicine,Department of Obstetrics and Gynecology

[16] Linkou Chang Gung Memorial Hospital and Chang Gung University Medical College,Department of Obstetrics and Gynecology

[17] Kurume University School of Medicine,Department of Obstetrics and Gynecology

[18] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gynecology

[19] Kitasato University School of Pharmacy,Department of Clinical Medicine (Biostatistics)

[20] Konkuk University School of Medicine,Department of Obstetrics and Gynecology

[21] Nippon Medical School Musashikosugi Hospital,Department of Medical Oncology

来源：

British Journal of Cancer | 2018年 / 119卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：530 / 537

页数：7

共 50 条

[1] Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Aoki, Yoichi
Ochiai, Kazunori
Lim, Soyi
Aoki, Daisuke
Kamiura, Shoji
Lin, Hao
Katsumata, Noriyuki
Cha, Soon-Da
Kim, Jae-Hoon
Kim, Byoung-Gie
Hirashima, Yasuyuki
Fujiwara, Keiichi
Kim, Young-Tak
Kim, Seok Mo
Chung, Hyun Hoon
Chang, Ting-Chang
Kamura, Toshiharu
Takizawa, Ken
Takeuchi, Masahiro
Kang, Soon-Beom
[J]. BRITISH JOURNAL OF CANCER, 2018, 119 (05) : 530 - 537
[2] A randomized phase III trial of cisplatin with or without S-1 in patients with FIGO IVB, recurrent, or persistent cervical cancer: An Asian study.
Lim, Soyi
Ochiai, Kazunori
Aoki, Yoichi
Aoki, Daisuke
Kamiura, Shoji
Lin, Hao
Fujiwara, Yasuhiro
Cha, Soon Do
Kim, Jae Hoon
Kim, Byoung
Hirashima, Yasuyuki
Fujiwara, Keiichi
Kim, Young Tak
Kim, Seok-Mo
Chung, Hyun Hoon
Chang, Ting-Chang
Kamura, Toshiharu
Takizawa, Ken
Takeuchi, Masahiro
Kang, Soon-Beom
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer
Brave, Michael
Dagher, Ramzi
Farrell, Ann
Abraham, Sophia
Ramchandani, Roshni
Gobburu, Jogarao
Booth, Brian
Jiang, Xiaoping
Sridhara, Rajeshwari
Justice, Robert
Pazdur, Richard
[J]. ONCOLOGY-NEW YORK, 2006, 20 (11): : 1401 - +
[4] A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
Moore, Kathleen N.
Herzog, Thomas J.
Lewin, Sharyn
Giuntoli, Robert L.
Armstrong, Deborah K.
Rocconi, Rodney P.
Spannuth, Whitney A.
Gold, Michael A.
[J]. GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 299 - 303
[5] Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
Moore, DH
Blessing, JA
McQuellon, RP
Thaler, HT
Cella, D
Benda, J
Miller, DS
Olt, G
King, S
Boggess, JF
Rocereto, TF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3113 - 3119
[6] Phase II study of S-1 in patients with advanced or recurrent cervical cancer
Hirai, Y.
Katsumata, N.
Kamiura, S.
Sugiyama, T.
Kokawa, K.
Hatae, M.
Nishimura, R.
Ochiai, K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[7] Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Monk, Bradley J.
Sill, Michael W.
McMeekin, D. Scott
Cohn, David E.
Ramondetta, Lois M.
Boardman, Cecelia H.
Benda, Jo
Cella, David
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4649 - 4655
[8] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
Noriyuki Hirahara
Takeshi Matsubara
Shunsuke Kaji
Tetsu Yamamoto
Ryoji Hyakudomi
Kiyoe Takai
Kazunari Ishitobi
Yuki Uchida
Yoshitsugu Tajima
[J]. BMC Cancer, 21
[9] A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
Tanaka, Yusaku
Kunisaki, Chikara
Izumisawa, Yusuke
Makino, Hirochika
Kimura, Jun
Sato, Sho
Miyamoto, Hiroshi
Kosaka, Takashi
Ono, Hidetaka A.
Takahashi, Masazumi
Sato, Kei
Akiyama, Hirotoshi
Endo, Itaru
[J]. ANTICANCER RESEARCH, 2018, 38 (10) : 6015 - 6021
[10] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
Hirahara, Noriyuki
Matsubara, Takeshi
Kaji, Shunsuke
Yamamoto, Tetsu
Hyakudomi, Ryoji
Takai, Kiyoe
Ishitobi, Kazunari
Uchida, Yuki
Tajima, Yoshitsugu
[J]. BMC CANCER, 2021, 21 (01)

← 1 2 3 4 5 →